Fox Run Management’s Ascendis Pharma ASND Stock Holding History

Fox Run Management’s Portfolio ASND Stock Details ASND Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$331K	Buy
2024 Q3	–	Sell
2024 Q2	$493K	Buy
2024 Q1	–	Sell
2023 Q4	$376K	Buy
2023 Q2	–	Sell
2023 Q1	$475K	Buy